All companies
Visit website
Supersapiens
OperatingTT1 Products, Inc.
Healthcare · Fitness · Founded 2019
Woman-founded
Real-time biometrics insights | Unlocking human health and performance
Valuation cap ⓘ
$120.0M
As of Mar 2024 · from Supersapiens Crowd Convertible Promissory Note 2 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$1,545,053
Across 2 rounds since 2023
Financials
FY2021–FY2022 · from SEC filings · hover any figure for its source$1.8M
−$14.2M
2021
$2.1M
−$9.9M
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
Income statement
Revenue
$1,832,611
$2,145,911
Cost of goods sold
$2,709,094
$1,269,636
Gross margin
-48%
41%
Net income
-$14,197,534
-$9,935,541
Taxes paid
$1,517
$0
Balance sheet
Cash
$571,660
$257,032
Accounts receivable
$14,874
$21,365
Total assets
$5,125,416
$9,355,330
Short-term debt
$2,151,423
$11,610,967
Long-term debt
$14,294,462
$11,586,147
Total liabilities
$16,445,885
$23,197,114
Other
Headcount
—
12
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$85.0M
Valuation cap
$120.0M
Valuation cap
Supersapiens Crowd Convertible Promissory Note 1
Supersapiens Crowd Convertible Promissory Note 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $310.1K / $3.8MInvestors 246Valuation cap $120M
Raised $1.2M / $1.2MInvestors 376Valuation cap $85M
Reg CF annual-report compliance
Delinquent
Filed 1 of 3 annual reports (FY2023–FY2025)
Missing: 2023, 2024, 2025
376 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001970837
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.